Metropolitan Life Insurance Company (MetLife)’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CYRX
BCM
CCM
FAM
Metropolitan Life Insurance Company (MetLife)'s CYRX Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of CryoPort (CYRX) in Q2 2024, closing a stake of 2,380 shares — an estimated $42.1K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in CYRX in Q2 2018 and held it in 24 quarters. The position peaked at $724K in Q3 2021. 160 funds tracked by Wall St. Rank hold CYRX as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining CryoPort position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,380 CryoPort shares in Q2 2024, an estimated $42.1K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in CryoPort in Q2 2018 and held it in 24 quarters.
- Metropolitan Life Insurance Company (MetLife)'s CryoPort position peaked at $724K in Q3 2021.
- 160 funds tracked by Wall St. Rank held CryoPort as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.